Related Experiment Video
Updated: Jan 17, 2026

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
Published on: May 27, 2022
Personalized pulse wave propagation modeling to improve vasopressor dosing management in patients with severe
Kamil Wolos1, Leszek Pstras1, Urszula Bialonczyk1
1Laboratory of Mathematical Modeling of Physiological Processes, Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland.
Abstract:
This study investigates whether examining the shape of arterial pulse waves and fitting to them a physiology-based mathematical model of pulse wave propagation can provide additional insights into the state of the cardiovascular system in patients with severe traumatic brain injury (sTBI), potentially enhancing vasopressor dosing strategies. We conducted a longitudinal study on 25 sTBI patients in an intensive care unit. Arterial pulse waves were recorded non-invasively from wrists and ankles using an oscillometric method and were used to inform a 0-1D model of the arterial blood flow dynamics. Model-estimated, patient-specific cardiovascular parameters were then used in a statistical model to predict changes in the administered dose of vasopressor (norepinephrine) in the next 24 hours. The model fits to the recorded pulse waves were satisfactory, with the coefficients of determination ([Formula: see text]) of approximately 0.9 and the differences between the measured and model-estimated mean arterial pressure of 0.1 ± 1.0 mmHg ([Formula: see text]=0.99). Except for a few patients, we found no clear association between the model-estimated parameters and norepinephrine dose at the time of pulse wave recording. Nevertheless, our predictive model achieved a balanced accuracy of 0.85 when trained and tested on the entire dataset and 0.76 when using the leave-one-out cross-validation, with 8 misclassifications among the total of 77 observations. Thus, despite the known inter-patient variability of hemodynamic response to vasopressors, the proposed method allowed predicting the direction of norepinephrine dose changes in the next 24 hours with satisfactory accuracy. Subject to further studies and extensive validation, our approach could inform a decision-support tool for optimizing vasopressor dosing on a per-patient basis.

